Chen L - Search Results

1

KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.

Xiong Y, Ju L, Yuan L, Chen L, Wang G, Xu H, Peng T, Luo Y, Xiao Y, Wang X. Xiong Y, et al. Among authors: chen l. Oncogene. 2021 Mar;40(9):1595-1608. doi: 10.1038/s41388-020-01634-z. Epub 2021 Jan 15. Oncogene. 2021. PMID: 33452459

2

TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells.

Wang G, Cao R, Qian K, Peng T, Yuan L, Chen L, Cheng S, Xiong Y, Ju L, Wang X, Xiao Y. Wang G, et al. Among authors: chen l. Onco Targets Ther. 2020 Sep 4;13:8825-8835. doi: 10.2147/OTT.S257056. eCollection 2020. Onco Targets Ther. 2020. PMID: 32943886 Free PMC article.

3

Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.

Luo Y, Chen L, Zhou Q, Xiong Y, Wang G, Liu X, Xiao Y, Ju L, Wang X. Luo Y, et al. Among authors: chen l. J Cell Mol Med. 2020 Nov;24(22):13370-13382. doi: 10.1111/jcmm.15960. Epub 2020 Oct 13. J Cell Mol Med. 2020. PMID: 33048468 Free PMC article.

4

Epigenetic signature predicts overall survival clear cell renal cell carcinoma.

Wang Y, Chen L, Ju L, Qian K, Wang X, Xiao Y, Wang G. Wang Y, et al. Among authors: chen l. Cancer Cell Int. 2020 Nov 23;20(1):564. doi: 10.1186/s12935-020-01640-x. Cancer Cell Int. 2020. PMID: 33292239 Free PMC article.

5

Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.

Xing Y, Chen L, Gu H, Yang C, Zhao J, Chen Z, Xiong M, Kazobinka G, Liu Y, Hou T. Xing Y, et al. Among authors: chen z, chen l. Oncogene. 2021 Mar;40(11):2051-2064. doi: 10.1038/s41388-021-01693-w. Epub 2021 Feb 22. Oncogene. 2021. PMID: 33619322

6

Corrigendum to "TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells" [Cancer Lett. 414 (1 February 2018) 278-293].

Cao R, Wang G, Qian K, Chen L, Ju L, Qian G, Wu CL, Dan HC, Jiang W, Wu M, Xiao Y, Wang X. Cao R, et al. Among authors: chen l. Cancer Lett. 2022 Jan 28;525:198-199. doi: 10.1016/j.canlet.2021.11.013. Epub 2021 Nov 14. Cancer Lett. 2022. PMID: 34785090 No abstract available.

7

Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Chen L, Cao R, Wang G, Yuan L, Qian G, Guo Z, Wu CL, Wang X, Xiao Y. Chen L, et al. Med Oncol. 2022 Sep 7;39(12):184. doi: 10.1007/s12032-022-01785-x. Med Oncol. 2022. PMID: 36071297 No abstract available.

8

RSPO3 promotes the aggressiveness of bladder cancer via Wnt/β-catenin and Hedgehog signaling pathways.

Chen Z, Zhou L, Chen L, Xiong M, Kazobinka G, Pang Z, Hou T. Chen Z, et al. Among authors: chen l. Carcinogenesis. 2019 Apr 29;40(2):360-369. doi: 10.1093/carcin/bgy140. Carcinogenesis. 2019. PMID: 30329043

9

NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.

Xiong M, Chen L, Zhou L, Ding Y, Kazobinka G, Chen Z, Hou T. Xiong M, et al. Among authors: chen z, chen l. Theranostics. 2019 Sep 23;9(24):7156-7167. doi: 10.7150/thno.36030. eCollection 2019. Theranostics. 2019. PMID: 31695759 Free PMC article.

10

Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.

Chen L, Yang X, Zhao J, Xiong M, Almaraihah R, Chen Z, Hou T. Chen L, et al. Among authors: chen z. J Exp Clin Cancer Res. 2020 May 27;39(1):94. doi: 10.1186/s13046-020-01592-0. J Exp Clin Cancer Res. 2020. PMID: 32460831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81,690 results

Search Page